Synaptic defects in type I spinal muscular atrophy in human development

被引:63
|
作者
Martinez-Hernandez, Rebeca [1 ,2 ]
Bernal, Sara [1 ,2 ]
Also-Rallo, Eva [1 ,2 ]
Alias, Laura [1 ,2 ]
Jesus Barcelo, Ma [1 ,2 ]
Hereu, Marta [3 ,4 ]
Esquerda, Josep E. [3 ,4 ]
Tizzano, Eduardo F. [1 ,2 ]
机构
[1] Hosp Santa Creu & Sant Pau, Dept Genet, Barcelona 08025, Spain
[2] IIB St Pau, Barcelona 08025, Spain
[3] IRBLLeida, Lleida, Spain
[4] Univ LLeida, Dept Expt Med, Unitat Neurobiol Cel Lular, Lleida, Spain
来源
JOURNAL OF PATHOLOGY | 2013年 / 229卷 / 01期
关键词
spinal muscular atrophy; neuromuscular junction; acetylcholine receptor; human development; WERDNIG-HOFFMANN DISEASE; MOTOR-NEURON PROTEIN; SMN2 COPY NUMBER; NEUROMUSCULAR-JUNCTION; MUSCLE-FIBERS; MOUSE MODELS; ACETYLCHOLINE-RECEPTOR; FETAL-DEVELOPMENT; DETERMINING GENE; NATURAL-HISTORY;
D O I
10.1002/path.4080
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Childhood spinal muscular atrophy is an autosomal recessive neuromuscular disorder caused by alterations in the Survival Motor Neuron 1 gene that triggers degeneration of motor neurons within the spinal cord. Spinal muscular atrophy is the second most common severe hereditary disease of infancy and early childhood. In the most severe cases (type I), the disease appears in the first months of life, suggesting defects in fetal development. However, it is not yet known how motor neurons, neuromuscular junctions, and muscle interact in the neuropathology of the disease. We report the structure of presynaptic and postsynaptic apparatus of the neuromuscular junctions in control and spinal muscular atrophy prenatal and postnatal human samples. Qualitative and quantitative data from confocal and electron microscopy studies revealed changes in acetylcholine receptor clustering, abnormal preterminal accumulation of vesicles, and aberrant ultrastructure of nerve terminals in the motor endplates of prenatal type I spinal muscular atrophy samples. Fetuses predicted to develop milder type II disease had a similar appearance to controls. Postnatal muscle of type I spinal muscular atrophy patients showed persistence of the fetal subunit of acetylcholine receptors, suggesting a delay in maturation of neuromuscular junctions. We observed that pathology in the severe form of the disease starts in fetal development and that a defect in maintaining the initial innervation is an early finding of neuromuscular dysfunction. These results will improve our understanding of the spinal muscular atrophy pathogenesis and help to define targets for possible presymptomatic therapy for this disease. Copyright (C) 2012 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.
引用
收藏
页码:49 / 61
页数:13
相关论文
共 50 条
  • [1] Synaptic defects in spinal muscular atrophy animal models
    Torres-Benito, Laura
    Ruiz, Rocio
    Tabares, Lucia
    DEVELOPMENTAL NEUROBIOLOGY, 2012, 72 (01) : 126 - 133
  • [2] Synaptic Defects in the Spinal and Neuromuscular Circuitry in a Mouse Model of Spinal Muscular Atrophy
    Ling, Karen K. Y.
    Lin, Ming-Yi
    Zingg, Brian
    Feng, Zhihua
    Ko, Chien-Ping
    PLOS ONE, 2010, 5 (11):
  • [3] Spinal muscular atrophy-type I
    Hardart, MKM
    Truog, RD
    ARCHIVES OF DISEASE IN CHILDHOOD, 2003, 88 (10) : 848 - 850
  • [4] Developmental milestones in type I spinal muscular atrophy
    De Sanctis, Roberto
    Coratti, Giorgia
    Pasternak, Amy
    Montes, Jacqueline
    Pane, Marika
    Mazzone, Elena S.
    Young, Sally Dunaway
    Salazar, Rachel
    Quigley, Janet
    Pera, Maria C.
    Antonaci, Laura
    Lapenta, Leonardo
    Glanzman, Allan M.
    Tiziano, Danilo
    Muntoni, Francesco
    Darras, Basil T.
    De Vivo, Darryl C.
    Finkel, Richard
    Mercuri, Eugenio
    NEUROMUSCULAR DISORDERS, 2016, 26 (11) : 754 - 759
  • [5] Drug treatment for spinal muscular atrophy type I
    Wadman, Renske I.
    Bosboom, Wendy M. J.
    van der Pol, W. Ludo
    van den Berg, Leonard H.
    Wokke, John H. J.
    Iannaccone, Susan T.
    Vrancken, Alexander F. J. E.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2012, (04):
  • [6] Drug treatment for spinal muscular atrophy type I
    Bosboom, Wendy M. J.
    Vrancken, Alexander F. J. E.
    van den Berg, Leonard H.
    Wokke, John H. J.
    Iannaccone, Susan T.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2009, (01):
  • [7] Spectrum of Neuropathophysiology in Spinal Muscular Atrophy Type I
    Harding, Brian N.
    Kariya, Shingo
    Monani, Umrao R.
    Chung, Wendy K.
    Benton, Maryjane
    Yum, Sabrina W.
    Tennekoon, Gihan
    Finkel, Richard S.
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2015, 74 (01): : 15 - 24
  • [8] Drug treatment for spinal muscular atrophy type I
    Wadman, Renske I.
    Bosboom, Wendy M. J.
    van den Berg, Leonard H.
    Wokke, John H. J.
    Iannaccone, Susan T.
    Vrancken, Alexander F. J. E.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2011, (12):
  • [9] Drug treatment for spinal muscular atrophy type I
    Wadman, Renske I.
    van der Pol, W. Ludo
    Bosboom, Wendy M. J.
    Asselman, Fay-Lynn
    van den Berg, Leonard H.
    Iannaccone, Susan T.
    Vrancken, Alexander F. J. E.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2019, (12):
  • [10] Synaptic Defects in the Peripheral and Central Nervous Systems in a Mouse Model of Spinal Muscular Atrophy
    Ling, Karen K. Y.
    Lin, Mingyi
    Feng, Zhihua
    Gibbs, Rebecca
    Ko, Chien-Ping
    NEUROLOGY, 2011, 76 (09) : A555 - A555